Julian E. Davies
Affiliations: | 1967-1980 | Biochemistry | University of Wisconsin, Madison, Madison, WI |
| 1985-1992 | Genetic Microbiology | Institut Pasteur, Paris, Paris, France | |
| 1992-1997 | Microbiology and Immunology | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
antibiotics and vaccinesWebsite:
http://www.encyclopedia.com/doc/1G2-3409800162.htmlGoogle:
"Julian E. Davies"Bio:
http://thesbn.ca/_blog/career_qna/post/dr_julian_davies/
DOI: 10.1039/JR9600002169
Mean distance: (not calculated yet)
Cross-listing: Microtree
Parents
Sign in to add mentor| John Cyril Roberts | grad student | 1956 | Nottingham | |
| (The chemistry of some mould metabolites.) | ||||
| Gilbert Stork | post-doc | Columbia | ||
| Eugene van Tamelen | post-doc | UW Madison | ||
Children
Sign in to add trainee| Kevin T. Chow | grad student | 2000 | UBC (Microtree) |
| Richard Y. Kao | grad student | 2000 | UBC (Microtree) |
| Patrice Courvalin | post-doc | 1974-1977 | UW Madison (ID Tree) |
| Yossef Av-Gay | post-doc | 1994-1996 | UBC (Microtree) |
| Keqian Yang | post-doc | 1998-1999 |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gao P, Wei Y, Wan RE, et al. (2022) Subinhibitory Concentrations of Antibiotics Exacerbate Staphylococcal Infection by Inducing Bacterial Virulence. Microbiology Spectrum. e0064022 |
| Gao P, Wei Y, Tai SSC, et al. (2022) Antivirulence Agent as an Adjuvant of β-Lactam Antibiotics in Treating Staphylococcal Infections. Antibiotics (Basel, Switzerland). 11 |
| Balasubramaniam D, Schroeder O, Russell AM, et al. (2022) An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. Journal of Lipid Research. 100198 |
| Laing ED, Weiss CD, Samuels EC, et al. (2022) Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers. Emerging Infectious Diseases. 28 |
| Goguet E, Powers JH, Olsen CH, et al. (2022) Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care Workers. Open Forum Infectious Diseases. 9: ofac030 |
| Coggins SA, Laing ED, Olsen CH, et al. (2021) Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers. Open Forum Infectious Diseases. 9: ofab575 |
| Okragly AJ, Corwin KB, Elia M, et al. (2021) Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33. Journal of Inflammation Research. 14: 3823-3835 |
| Coggins SAA, Laing ED, Olsen CH, et al. (2021) Adverse effects and antibody titers in response to the BNT162b2 mRNA COVID-19 vaccine in a prospective study of healthcare workers. Medrxiv : the Preprint Server For Health Sciences |
| Jackson-Thompson BM, Goguet E, Laing ED, et al. (2021) Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. Bmc Infectious Diseases. 21: 544 |
| Jones BE, Brown-Augsburger PL, Corbett KS, et al. (2021) The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates. Science Translational Medicine |